Kuehn Law Encourages Investors of Merck & Co., Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - May 1, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Merck & Co., Inc. (NYSE: MRK) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Insiders at Merck caused the company to misrepresent or fail to disclose material information concerning Merck's expected revenue of $11 billion from sales of Gardasil by 2030, including, among other things, confidence in Merck's purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil's growth in China.

If you currently own MRK and purchased prior to February 3, 2022 please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250518